-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704.P1.85 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster I

Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Fabian Mueller, MD1*, Simon Voelkl, PhD1*, Dimitrios Mougiakakos, MD1,2, Sebastian Boeltz3*, Michael Aigner, PhD1*, Regina Gary, PhD1*, Sascha Kretschmann, PhD1*, Soraya Kharboutli, MD1*, Arnd Kleyer3*, David Simon3*, Wolf Rösler1*, Katharina M Habenicht4*, Thomas H Winkler, PhD4*, Gerhard Krönke3*, Georg Schett, MD3* and Andreas Mackensen, MD1*

1Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen, Germany
2Otto von Guericke University Magdeburg, Magdeburg, Germany
3Department of Internal Medicine 3, University Hospital of Erlangen, Erlangen, Germany
4Department of Biology, Divison of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany

Wenming Chen, MD. PhD1*, Chengcheng Fu, MD2*, Baijun Fang, M.D., Ph.D.3*, Aibin Liang, MD, PhD4*, Zhongjun Xia, MD, PhD5, Yanjuan He, MD6*, Jin Lu, MD7, Hui Liu, MD8*, Ming Hou, MD9, Zhen Cai, PhD, MD10*, Wei Yang, MD11*, Siguo Hao, MD, PhD12*, Songfu Jiang, MD13*, Hongmei Jing, MD14, Jing Liu, MD, PhD15*, Xin Du16*, Rong Fu, MD17*, Heng Mei18*, Zunmin Zhu, MD19*, Yanli Yang, MD20*, Hong Liu, MD21*, Daijing Yuan, MD22*, Hongxia Zhao, MD, PhD22*, Jun Xiao, MD22*, Wei Wang, MD, PhD22*, Huamao Wang, PhD22* and Zonghai LI, MD, PhD22*

1Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
2MD, PhD, The First Affilliated Hospital of Soochow University, Suzhou, CHN
3Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
4School of Medicine, Tongji Hospital of Tongji University, Shanghai, China
5Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
6Department of Hematology, Xiangya Hospital; Central South University, changsha, China
7Institute of Hematology of Peking University, Beijing, Beijing, China
8Department of Hematology, Beijing Hospital, Beijing, China
9Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
10Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
11Shengjing Hospital of China Medical University, Shenyang, China
12Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
13The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
14Department of Hematology, Peking University Third Hospital, Beijing, China
15Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China
16Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
17Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
18Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
19Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, China
20The First Affiliated Hospital of Bengbu Medical Collegue, Bengbu, China
21Affiliated Hospital of Nantong University, Nantong, CHN
22CARsgen Therapeutics Co. Ltd, Shanghai, China

Xian Zhang1,2, Yali Zhou3*, Junfang Yang1,2*, Jingjing Li1,2*, Liyuan Qiu2*, Wengang Ge3*, Bo Pei3*, Jie Chen3*, Lu Han3*, Jiangtao Ren, PHD3* and Peihua Lu, MD1,2

1Beijing Lu Daopei Institute of Hematology, Beijing, China
2Hebei Yanda Lu Daopei Hospital, Langfang, China
3Nanjing Bioheng Biotech Co., Ltd, Nanjing, China

Federico Lussana, MD, PhD1*, Chiara Francesca Magnani, PhD2,3*, Giuseppe Gaipa, PhD3,4, Stefania Galimberti, PhD5*, Giuseppe Gritti, MD, PhD1*, Daniela Belotti4*, Sara Napolitano, MD6*, Chiara Buracchi, PhD, MSc7*, Gian Maria Borleri1*, Benedetta Rambaldi1,8*, Giuliana Rizzuto, MD1,9*, Anna Grassi, MD1*, Muriel Paganessi1*, Silvia Ferrari, MD1*, Sarah Tettamanti, PhD3*, Giovanni Gazzaniga, PhD3*, Chiara Capelli10,11*, Elisa Gotti12*, Martino Introna, MD10,12, Adriana Balduzzi, MD6, Maria Grazia Valsecchi, PhD5*, Giuseppe Dastoli, MD3*, Alessandro Rambaldi, MD13,14 and Andrea Biondi, MD, PhD3,4,6

1Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
2Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
3Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca/Fondazione MBBM, Monza, Italy
4Laboratorio di Terapia Cellulare e Genica Stefano Verri, ASST-Monza, Ospedale San Gerardo, Monza, Italy
5Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
6Department of Pediatrics, University of Milano - Bicocca, Fondazione MBBM, Monza, Italy
7Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca/Fondazione MBBM, Monza, MB, Italy
8PhD Program in Translational and Molecular Medicine (DIMET), University of Milano-Bicocca, Monza, Italy
9University of Milan, Milano, Italy
10USS Centro di Terapia Cellulare "G. Lanzani", Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
11Fondazione per la Ricerca Ospedale di Bergamo (FROM), Bergamo, Italy
12Centro di Terapia Cellulare "G. Lanzani", Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
13Department of Oncology and Hematology, University of Milan, Milan, Italy
14Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy

Antonio Perez, MD, PhD1,2*, Cristina Ferreras, PhD3*, Clara Hernandez, MD4*, Alejandro Martín-Quirós5*, Karima Al-Akioui6*, Marta Mora-Rillo7*, Fátima Ibáñez, MD8*, Rosa Goterris, MD, PhD9*, Raquel De Paz Arias, PhD10*, Pilar Guerra-García11*, Javier Queiruga-Parada12*, Pablo Molina13*, Merche Bou14*, Carmen Mestre-Durán6*, Alberto Borobia6,12*, Antonio J Carcas12,15*, María Luisa Briones16*, Jose Luis Vicario, PhD17*, Miguel Ángel Moreno17*, Antonio Balas, PhD17*, Cristina Eguizábal, PhD18,19*, Bernat Soria, PhD20,21* and Carlos Solano, MD, PhD22,23,24

1Hospital La Paz Institute for Health Research, Madrid, Spain
2Hemato-Oncology Pediatric Service, Hospital Universitario La Paz, Madrid, Spain
3Translational Research In Pediatric Oncology, Hematopoietic Transplantation and, Madrid, ESP
4Internal Medicine, Hospital Enfermera Isabel Zendal, Madrid, Spain
5Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain, Madrid, Spain
6Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain, Madrid, Spain
7Diseases Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Madrid, Spain
8Internal Medicine, Hospital Puerta de Hierro, Madrid, Spain
9Hematology, Hospital Clinico Universitario de Valencia, Valencia, Spain
10Hematology, Hospital Universitario La Paz-Idipaz, Madrid, ESP
11Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid, Spain., Madrid, Spain
12Clinical Pharmacology Department University Hospital La Paz, Madrid, Spain., Madrid, Spain
13Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain
14Clinical Trial Unit, Hospital Clínico, Valencia, Spain, Valencia, Spain
15Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain, Madrid, Spain
16Neumology Department, Hospital Clínico, Valencia, Spain, Valencia, Spain
17Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain, Madrid, Spain
18Research Unit, Basque Centre for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Bizkaia, Spain, Galdakao, Spain
19Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Barakaldo, Spain
20University Pablo de Olavide, Sevilla, Spain, Sevilla, Spain
21Health Research Institute-ISABIAL, Alicante University Hospital and Institute of Bioengineering, Miguel Hernández University., Alicante, Spain
22Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
23Department of Medicine, University of Valencia, Valencia, Spain
24Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain

Chenggong Li1*, Xindi Wang1*, Zhuolin Wu1*, Wenjing Luo1*, Yinqiang Zhang1*, Yun Kang2*, Jia Xu2*, Zhongpei Huang1*, Mengyi Du1*, Lu Tang1*, Jianghua Wu1*, Danying Liao1*, Haiming Kou1*, Cong Lu1*, Huiwen Jiang1*, Qiuzhe Wei1*, Sha Ke1*, Jing'e Zheng2*, Wei Xiong3*, Jun Deng, MD, Ph.D1*, Yu Hu1* and Heng Mei1*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Wuhan Sian Medical Technology Co., Ltd, Wuhan, China

Francesca Farina, MD1*, Bernhard Gentner, MD, PhD1, Gaetano Finocchiaro, MD2*, Marica Eoli, MD3*, Alessia Capotondo, PhD4*, Elena Anghileri, MD3*, Matteo Barcella, PhD5*, Valentina Brambilla6*, Maria Grazie Bruzzone, MD7*, Matteo Giovanni Carrabba, MD1*, Valeria Cuccarini, MD7*, Giorgio D'Alessandris, MD8*, Francesco Di Meco, MD9*, Valeria Ferla, MD1*, Alberto Franzin, MD10*, Paolo Ferroli, MD9*, Filippo Gagliardi, MD11*, Federico Legnani, MD9*, Stefania Mazzoleni, PhD6*, Pietro Mortini, MD11*, Matteo Maria Naldini, MD5*, Alessandro Olivi, MD8*, Roberto Pallini, MD8*, Monica Patanè12*, Rosina Paterra3*, Bianca Pollo, MD12*, Marco Saini, MD9*, Silvia Snider, MD11*, Andrew Zambanini, MBBS, MRCP6*, Luigi Naldini, MD, PhD4*, Carlo Russo, MD13* and Fabio Ciceri, MD1*

1Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milano, Italy
2Neuro-Oncology Unit, IRCCS San Raffaele Hospital, Milan, Italy
3Neuro-Oncology Unit, IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
4San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), San Raffaele Scientific Institute, Milano, Italy
5San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute, Milan, Italy
6Genenta Science, Milano, Italy
7Neuroradiology Unit, IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
8Neurosurgery Unit, Policlinico Gemelli, Rome, Italy
9Neurosurgery Unit, Istituto Neurologico Carlo Besta, Milan, Italy
10Neurosurgery Unit, Fondazione Poliambulanza, Brescia, Italy
11Neurosurgery Unit, IRCCS San Raffaele Hospital, Milano, Italy
12Neuropathology Unit, IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
13Genenta Science, New York

Amitkumar Mehta, MD1, Umar Farooq, MD2, Andy Chen, MD, PhD3, Joseph P. McGuirk, DO4, Thomas Ly, PhD5*, Lilly Wong, PhD5*, Sarah Cooley, MD5, Bahram Valamehr5, Rebecca Elstrom, MD5, Yu-Waye Chu, MD5 and Jae H Park, MD6

1Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
2Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
3Oregon Health and Science University, Portland, OR
4The University of Kansas Medical Center, Kansas City, KS
5Fate Therapeutics, Inc., San Diego, CA
6Memorial Sloan-Kettering Cancer Ctr., New York, NY

Robert Chiesa, MD1*, Christos Georgiadis, PhD2*, Giorgio Ottaviano, MD1,2*, Farhatullah Syed, PhD2,3*, Toni Braybrook2*, Annie Etuk, PhD2*, Hong Zhan, MD, PhD2*, Soragia Athina Gkazi, PhD2*, Roland Preece2*, Stuart Adams, PhD4*, Rebecca Thomas5*, Arnold Awuah6*, Kimberly Gilmour, PhD6*, Lana Mhaldien6*, Jan Chu1*, Danielle Pinner1*, Agnieszka Kubat2*, Paul Veys1*, Kanchan Rao, MD1*, Giovanna Lucchini, MD1*, David O'Connor, MD5,7*, Ajay Vora, MD5 and Waseem Qasim, MBBS, PhD2*

1Department of Blood and Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom
2Molecular and Cellular Immunology Unit, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
3King Faisal Specialist Hospital & Research Centre (KFSH&RC), Riyadh, Saudi Arabia
4SIHMDS-Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
5Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
6Department of Immunology, Great Ormond Street Hospital for Children, London, United Kingdom
7UCL Cancer Institute, Department of Haematology, University College London, London, United Kingdom

Tatjana Holzer1*, Stefanie Biedermann, PhD1*, Inga Herfort, PhD1*, Birte Friedrichs, MD2*, Silke Holtkamp, PhD2*, Linda Hanssens, MPH, PhD2*, Mario Assenmacher, PhD1*, Ulf Bethke1*, Dina Schneider, PhD3, Stefan Miltenyi1,2,3*, Toon Overstijns, MD1,2*, Christoph Schmid, MD4*, Francis A. Ayuk, MD5*, Christoph Scheid, MD6*, Anja Jühling7*, Udo Holtick, MD, PhD6*, Philipp Gödel, MD7*, Peter Borchmann8 and Iris Bürger, PhD1*

1Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
2Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany
3Lentigen Technology Inc., A Miltenyi Company, Gaithersburg, MD
4Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
5Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6Leukapheresis and Stem Cell Transplant Unit, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
7Cologne Lymphoma Working Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
8Cologne Lymphoma Working Group, Department of Internal Medicine I, University Hospital of Cologne, Koeln, Germany

Swati Naik, MBBS1, Renee M. Madden, MS, MD2*, Amanda Lipsitt3*, Timothy Lockey, PhD4*, Jennyfer Bran, MD3*, Jeffrey E. Rubnitz, MD5, Jeffery Klco, MD, PhD6, Barry Shulkin, MD7*, Sagar L Patil8*, Sarah Schell8*, Jeoungeun John Park3*, Janice Riberdy, PhD9*, Na Shang3*, Jaquelyn T. Zoine, PhD8, Jennifer Wallace3*, Elaine Harstead3*, Catherine Willis8*, Jean-Yves Metais, Ph.D.2*, Deanna M Langfitt, PhD2*, Sheng Zhou, PhD10, Salem M. Akel, PhD11*, Michael M Meagher, PhD4*, Brandon M Triplett, MD2*, Stephen Gottschalk, MD2 and Mireya Paulina Velasquez, MD2

1Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TX
2Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
3ST. JUDE CHILDREN'S RESEARCH HOSPITAL, Memphis, TX
4Department of Therapeutics Production and Quality, St. Jude Children's Research Hospital, Memphis, TN
5Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
6Department of Hematology, Saint Jude Children's Research Hospital, Memphis, TN
7Department of Diagnostic Imaging, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, TN
8St. Jude Children's Research Hospital, Memphis, TN
9Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
10Experimental Cellular Therapeutics Laboratory, St. Jude Children's Research Hospital, Memphis, TN
11St. Jude Children’s Research Hospital, Memphis, TN

Binod Dhakal, MBBS1, Jesus G Berdeja, MD2, Tara Gregory, MD3*, Thomas Ly, PhD4*, Cara Bickers, PhD4*, Xingyue Zong, PhD4*, Lilly Wong, PhD4*, Jode P Goodridge4*, Sarah Cooley, MD4, Bahram Valamehr4, Yu-Waye Chu, MD4, John Byon, MD, PhD4 and Rafat Abonour, MD5

1Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
2Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
3Colorado Blood Cancer Institute, Sarah Cannon Cancer Network, Denver, CO
4Fate Therapeutics, Inc., San Diego, CA
5Indiana University School of Medicine, Indianapolis, IN

Caron A. Jacobson, MD1, Tilanthi Jayawardena, PhD2*, Lou Yu, MS3*, Jason Hallman2*, Robert Schmittling2*, Erin Cuneo2*, Ian Belle, PhD2*, Gavin Sampey, PhD2*, Danica Cabral2*, Ashleigh Derrick2*, Josie Tueller2*, Koen Van Besien, MD, PhD4,5, Scott R. Solomon, MD6,7, Adam J. Olszewski, MD8,9, Joseph E. Maakaron, MD10,11, Ran Reshef, MD, MSc12,13, Anthony S. Stein, MD14, Abhinav Deol, MD15, Nitin Jain, MD16, Alan F. List, MD2 and Bijal D. Shah, MD17,18

1Dana-Farber Cancer Institute, Boston, MA
2Precision BioSciences, Inc., Durham, NC
3Clinical Operations, Precision BioSciences, Inc., Durham, NC
4Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
5Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
6Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
7Blood and Marrow Transplant Program, BMT Group of Georgia, Atlanta, GA
8Division of Hematology/Oncology, Brown University, Providence, RI
9Rhode Island Hospital, Providence, RI
10Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
11Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
12Columbia Center for Translational Immunology, New York, NY
13Blood and Marrow Transplantation Program, Columbia University, New York, NY
14Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
15Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI
16Department of Leukemia, MD Anderson Cancer Center, Houston, TX
17H. Lee Moffitt Cancer Center, Tampa, FL
18Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Kim H. Orchard, MBBS, PhD1, Helena Ballestero, BSc2*, Aga Zubiak, MSc3*, Chris Dalley, MBBS, FRCPath4*, Deborah Susan Richardson, MD, FRCP, FRCPath, MA, MBBChir5, Rob Torrance3*, Trinity Eales3*, Dimitra Peppa, PhD6*, May Sabry, PhD3* and Mark W. Lowdell, PhD, FRCPath, FRSB7*

1Wessex Blood and Marrow Transplant and Cell Therapy Program, Southampton Univ. Hospitals, Southampton, ENG, United Kingdom
2Cancer Institute, University College London, London, United Kingdom
3University College London, London, United Kingdom
4University Hospital Southampton, Southampton, United Kingdom
5University Hospitals Southampton, Southampton, GBR
6Immunity & Transplantation, University College London, London, United Kingdom
7INmuneBio Inc, Boca Raton, FL

Yinqiang Zhang1,2*, Chenggong Li1,2*, Huiwen Jiang1,2*, Wenjing Luo1,2*, Mengyi Du1,2*, Fen Zhou1,3*, Lu Tang1,2*, Jianghua Wu1,2*, Qiuzhe Wei1,2*, Cong Lu1,2*, Haiming Kou1,2*, Di Wu4*, Chang Alex H5*, Heng Mei1,2* and Yu Hu1,2*

1Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Beijing GoBroad Hospital Management Co.,Ltd, Beijing, China
5Shanghai YaKe Biotechnology Ltd, Shanghai, China

Dasom Lee, MD1, Abida Poovathukaran Babu, MD2*, Salvatore A Corallo, BS3*, Meghan A Menges3*, Melanie J Hidalgo-Vargas, MS3*, Danielle M Ames3*, Aleksandr Lazaryan, MD, PhD, MPH3, Taiga Nishihori, MD3, Farhad Khimani, MD3, Sameh Gaballa, MD4, Bijal D. Shah, MD4, Javier Pinilla Ibarz, MD4, Julio C. Chavez, MD4, Michael D. Jain, MD, PhD3 and Frederick L. Locke, MD3

1Department of Hematology, Stanford University, Stanford, CA
2Department of Internal Medicine, University of South Florida, Tampa, FL
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

Wei Liu1*, Wenyang Huang, MD1*, Rui Lv1*, Huimin Liu1*, Shuhua Yi, MD1*, Hong Liu1*, Lulu Lv, PhD2*, Lugui Qiu1, Jianxiang Wang, MD1 and Dehui Zou1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2Juventas Cell Therapy Ltd., Tianjin, China

Larisa Shelikhova1*, Arina Rakhteenko1*, Olga Molostova2*, Elena Kurnikova2*, V Ukrainskaya1*, Yakov Muzalevsky1*, Dmitry Pershin1*, Alexander Popov1*, Elena Kulakovskaya1*, Dina Baidildina1*, Alexey Stepanov1*, Elena Osipova2*, Galina Novichkova1*, Alexey Maschan, MD1* and Michael Maschan1*

1Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
2Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

Yue Tan1*, Jing PAN, MD, PhD2, Biping Deng3*, Zhuojun Ling2*, Song Weiliang4*, Zhenglong Tian5*, Ming Cao5*, Jinlong Xu6*, Jiajia Duan7*, Zelin Wang4*, Kai Wang4* and Chunyu Li4*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Department of Hematology, Beijing Boren Hospital, Beijing, China
3Cytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China
4Beijing Boren Hospital, Beijing, China
5department of hospital management, Gobroad Medical Group, Beijing, China
6Department of Hematology, Beijing Boren Hospital, Beijing, Beijing, CHN
7Beijing Boren Hospital, Beijing, CHN

Xin Yang1*, Gaoxiang Wang, MD2*, Xiaoying Zhang3*, Qiuxia Yu4*, Yang Cao5* and Liang Huang, MD2

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech, Wuhan, China
4Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wu Han, AL, China
5Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CA, China

Yajing Zhang1*, Zhiqiang Wu, MD2*, Yao Wang, MD2*, Qingming Yang, MD3*, Yang Liu, MD3*, Chuan Tong4* and Weidong Han, PhD, MD5*

1Chinese PLA General Hospital, Beijing, China
2Molecule & Immunology Department, Chinese PLA General Hospital, Beijing, China
3Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China
4Chinese PLA General Hospital, Beijing, CHN
5Department of Molecular Biology and Immunology, Chinese PLA General Hospital, Beijing, China

Arnon P. Kater, MD, PhD1, Niels WCJ Van De Donk, MD2, Paula Rodríguez-Otero, MD, PhD3*, María Victoria Mateos, MD, PhD4, Francesc Bosch, MD, PhD5, Alessandra Tucci, MD6*, Paolo Ghia, MD, PhD7, Anton EP Adang, PhD8*, Paul W. H. I. Parren, PhD8*, Ilse Tuinhof, BS8*, Sanjana Umarale, MSc8*, Benjamin Winograd, MD, PhD8*, Hans J. Van Der Vliet, MD, PhD8* and Annemiek Broijl, MD, PhD9*

1Academic Medical Center, Amsterdam Zuidoost, NH, Netherlands
2Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, Netherlands, and Cancer Center Amsterdam, Amsterdam, Netherlands
3Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain
4Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain
5Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain
6Department of Hematology, ASST Spedali Civili, Brescia, Italy
7Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
8LAVA Therapeutics N.V., Utrecht, Netherlands
9Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Atharva Karulkar, PhD1,2*, Hasmukh Jain, MD, DM3*, Shreshtha Shah1*, Aalia Khan2*, Ankesh Jaiswal2*, Afrin Firfiray1,2*, Prashant Suvasia2*, Priyanshi Suvasia2*, Juber Pendhari2*, Sweety Asija2*, Ambalika Chowdury2*, Ankit Banik2*, Smrithi Ravikumar1*, Neha Sharma4*, Minal Poojary, MD5*, Sumathi Hiregoudar, MD6*, Preeti Desai, MD7*, Anisha Navkudkar, MD7*, Sunil Rajadhyaksha7*, Jayashree Thorat, MD, DM8*, Prashant R. Tembhare, MD9, Albeena Nisar, PhD10*, Manju Sengar, MD, DM 11, David F. Stroncek, MD12, Steven Highfill, PhD12*, Nirali N. Shah, MD13, Gaurav Narula, MD14* and Rahul Purwar, PhD1,2*

1Immunoadoptive Cell Therapy Pvt Ltd (ImmunoACT), Navi Mumbai, India
2Indian Institute of Technology Bombay, Mumbai, India
3Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
4Department of Medical Oncology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
5Tata Memorial Centre Affiliated to Homi Bhabha National Institute, Kharghar, India
6Department of Transfusion Medicine, ACTREC, Sector 22, Navi Mumbai, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Navi Mumbai, India
7Department of Transfusion Medicine, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
8Department of Medical Oncology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, Maharashtra, India
9Hematopathology Lab, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
10Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, AL, India
11Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
12Center for Cellular Engineering, National Institutes of Health, Bethesda, MD
13Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
14Department of Pediatric Oncology, Tata Memorial Center, Affiliated to Homi Bhabha National Institute, Mumbai, India

Jakub Svoboda, MD1, James N. Gerson, MD2, Daniel J. Landsburg, MD1, Elise A. Chong, MD1, Stefan K. Barta, MD1, Sunita Dwivedy Nasta, MD1, Marco Ruella, MD1,3, Elizabeth O. Hexner, MD, MSTR4, Amy Marshall3*, Rachel Leskowitz, PhD3*, Megan Four3*, Joanne Shea3*, Tina Matlawski3*, Amanda Cervini, RN3*, Megan M Davis, PhD3*, Mercy Gohil3*, John Scholler3*, Donald Hasenmayer3*, Juliana Rojas Amortegui3*, Andrea Brennan3*, Gabriela Plesa, MD, PhD3*, Wei-Ting Hwang, PhD5*, David L. Porter, MD6, Joseph Fraietta, PhD3*, Stephen J. Schuster, MD1* and Carl H June, MD3

1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Lymphoma Program, Abramson Cancer Center, Philadelphia, PA
3Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
4Blood and Marrow Transplantation Program, University of Pennsylvania, Philadelphia, PA
5Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
6Center for Cellular Therapy and Transplantation, University of Pennsylvania, Philadelphia, PA

Ibrahim Aldoss, MD1,2,3, Samer Khaled, MD4*, Xiuli Wang, MD PhD5, Joycelynne Palmer, PhD6*, Yan Wang, MS7*, Jamie R Wagner, BS8*, Mary C. Clark, PhD9*, Jennifer Simpson10*, Jinny Paul, PhD11*, Vibhuti Vyas, MS2*, Sheng-Hsuan Chien12*, Anthony S. Stein, MD13,14, Vinod A. Pullarkat, MD15*, Amandeep Salhotra, MD3,16, Monzr M. Al Malki, MD13, Sandra Thomas, PhD9, Elizabeth L. Budde, MD, PhD17, Guido Marcucci, MD18, Christine E Brown, PhD19* and Stephen J Forman, MD3,13

1City of Hope, Duarte, CA
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
4Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA
6Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA
7Department of Computational and Quantitative Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
8T Cell Therapeutics Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
9Department of Clinical and Translational Project Development, City of Hope, Duarte, CA
10City of Hope National Medical Center, Duarte, CA
11T Cell Therapeutics Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte
12Department of Hematology and Hematopoeitic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
13Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
14Gehr Family Leukemia Center, City of Hope, Duarte, CA
15Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA
16Department of Hematology and HCT, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
17Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
18Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
19T-Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Sattva S. Neelapu, MD1, Don A. Stevens, MD2, Mehdi Hamadani, MD3, Matthew J Frank, MD, PhD4, Houston Holmes, MD, MBA5*, Aya Jacobovits, PhD6*, John Hinkle, PhD7*, Jackie Kennedy-Wilde, MS6*, Ori Maller, PhD6*, Bayarmagnai Weinstein, MD, PhD6*, Francesco Galimi, MD, PhD6, Rose K Lai, MD6* and David B. Miklos, MD, PhD8

1Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
2Norton Healthcare, Norton Cancer Institute, Louisville, KY
3BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
4Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
5Baylor Charles A. Sammons Cancer Center, Dallas, TX
6Adicet Therapeutics Inc, Redwood City, CA
7EarlyPhase Sciences Inc, Austin, TX
8Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA

Sham Mailankody, MBBS 1, Jeffrey V. Matous, MD2, Michaela Liedtke, MD3, Surbhi Sidana, MD4, Olalekan O. Oluwole, MBBS5, Meera Mohan, MD, MS6*, Jose C. Cruz, MD7, Rajneesh Nath, MD8, Faiz Anwer, MD9*, Adriana Rossi, MD, MSc10, Myo Htut, MD11, Shahbaz A. Malik, MD12, Srinivas Ghatta, PhD13*, Myles Dillon, PhD13*, Wendy Ying, PhD13*, Lynn Navale, MS13*, Erin E. Karski, MD13*, Arun Balakumaran, MD13 and Shaji K Kumar, MD14

1Memorial Sloan Kettering Cancer Center, New York, NY
2Colorado Blood Cancer Institute, Denver, CO
3Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
4Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
5Vanderbilt University Medical Center, Nashville, TN
6Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
7Texas Transplant Institute, San Antonio, TX
8Banner MD Anderson Cancer Center, Scottsdale, AZ
9Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
10Icahn School of Medicine, Mount Sinai Hospital, New York, NY
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
12St. David's South Austin Medical Center, Austin, TX
13Allogene Therapeutics, South San Francisco, CA
14Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Hui Wang1*, Ying Gao, MD1*, Ding Zhang1*, Yan Zheng, MD1*, Xingxing Hu1*, Qiuying Gao1*, Ben Niu1*, Limin Hou1*, Ling Wang1*, Weihua Zhang1*, Yi Zhang1*, Xingli Ru1*, Le Li2*, Zuohan Peng, PhD2,3* and Yi Wang, MD1*

1Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, China
2Sunnycell Therapeutics Co., Ltd, Xi'an, China
3Faculty of Medicine, Northwest University, Xi'an, China

Zhenya Hong1*, Zhi Yang, PhD2*, Xiaoxi Zhou, MD1*, Gaoxiang Wang, MD1*, Mi Zhou1*, Yingzi Zhang2*, Peiling Zhang, MD1*, Jinjin Huang1*, Li Meng1*, Haitao Ruan1*, Min Xiao1*, Yunyan Li2*, Linling Wang2*, Meiling Wang2*, Wei Zhu2*, Qianzhen Zhang2*, Junjie Shen, PhD2*, Jianfeng Zhou, MD1*, Cheng Qian, MD2* and Liang Huang, MD1

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Chongqing Precision Biotech Co., Ltd., Chongqing, China

*signifies non-member of ASH